Cargando…
Pseudomonas Biofilms, Cystic Fibrosis, and Phage: a Silver Lining?
In contrast to usual laboratory conditions, most bacteria in the human body grow in biofilms. Encased in a structured matrix, many pathogens display heightened resistance to antibiotics. Pseudomonas aeruginosa lung infections in cystic fibrosis patients represent a prime example of the clinical chal...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Microbiology
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3322549/ https://www.ncbi.nlm.nih.gov/pubmed/22493030 http://dx.doi.org/10.1128/mBio.00061-12 |
_version_ | 1782229073914757120 |
---|---|
author | Brüssow, Harald |
author_facet | Brüssow, Harald |
author_sort | Brüssow, Harald |
collection | PubMed |
description | In contrast to usual laboratory conditions, most bacteria in the human body grow in biofilms. Encased in a structured matrix, many pathogens display heightened resistance to antibiotics. Pseudomonas aeruginosa lung infections in cystic fibrosis patients represent a prime example of the clinical challenges that antibiotic resistance in biofilms can represent. In the March 6, 2012 issue of mBio, Colin Hill and his colleagues report on experiments that add to the evidence that Pseudomonas phages are a potential treatment option for these infections. |
format | Online Article Text |
id | pubmed-3322549 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | American Society of Microbiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-33225492012-04-16 Pseudomonas Biofilms, Cystic Fibrosis, and Phage: a Silver Lining? Brüssow, Harald mBio Commentary In contrast to usual laboratory conditions, most bacteria in the human body grow in biofilms. Encased in a structured matrix, many pathogens display heightened resistance to antibiotics. Pseudomonas aeruginosa lung infections in cystic fibrosis patients represent a prime example of the clinical challenges that antibiotic resistance in biofilms can represent. In the March 6, 2012 issue of mBio, Colin Hill and his colleagues report on experiments that add to the evidence that Pseudomonas phages are a potential treatment option for these infections. American Society of Microbiology 2012-04-03 /pmc/articles/PMC3322549/ /pubmed/22493030 http://dx.doi.org/10.1128/mBio.00061-12 Text en Copyright © 2012 Brüssow http://creativecommons.org/licenses/by-nc-sa/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-nc-sa/3.0/) , which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Commentary Brüssow, Harald Pseudomonas Biofilms, Cystic Fibrosis, and Phage: a Silver Lining? |
title |
Pseudomonas Biofilms, Cystic Fibrosis, and Phage: a Silver Lining? |
title_full |
Pseudomonas Biofilms, Cystic Fibrosis, and Phage: a Silver Lining? |
title_fullStr |
Pseudomonas Biofilms, Cystic Fibrosis, and Phage: a Silver Lining? |
title_full_unstemmed |
Pseudomonas Biofilms, Cystic Fibrosis, and Phage: a Silver Lining? |
title_short |
Pseudomonas Biofilms, Cystic Fibrosis, and Phage: a Silver Lining? |
title_sort | pseudomonas biofilms, cystic fibrosis, and phage: a silver lining? |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3322549/ https://www.ncbi.nlm.nih.gov/pubmed/22493030 http://dx.doi.org/10.1128/mBio.00061-12 |
work_keys_str_mv | AT brussowharald pseudomonasbiofilmscysticfibrosisandphageasilverlining |